MRF-Logo2019-Horizontal-RGB
another research opportunity
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

another research opportunity

› Forums › General Melanoma Community › another research opportunity

  • Post
    • August 29, 2013 at 5:13 pm
    LynnLuc
    Participant

      Wanted:

      • Stage III resected Melanoma patients that  are current using an interferon therapy
      • Stage III resected Melanoma patients that  did use an interferon therapy but have discontinued within the past year
      • Stage III resected Melanoma patients that either chose, or were advised, to have observation of their cancer rather than an interferon.

       

      They will pay $100 to each patient for the telephone interview, $75 for the online survey.  Send you e-mail address and info to contact you and I will forward it on.

      Wanted:

      • Stage III resected Melanoma patients that  are current using an interferon therapy
      • Stage III resected Melanoma patients that  did use an interferon therapy but have discontinued within the past year
      • Stage III resected Melanoma patients that either chose, or were advised, to have observation of their cancer rather than an interferon.

       

      They will pay $100 to each patient for the telephone interview, $75 for the online survey.  Send you e-mail address and info to contact you and I will forward it on.

      My e-mail is [email protected]

    Viewing 2 reply threads
    • Replies
        • August 29, 2013 at 7:59 pm
        LynnLuc
        Participant

          PS    Leger is an independent market research company contracted by Merck to do a study for them . The objective of the study is to understand the impact of a new pen device instead of the current reconstitution  process on the interest, acceptance of physician recommendations to use interferon vs observation, and the likely duration of compliance with the new device.  The current process is complicated- diluent is added to the vial that is then drawn up and injected- the pen is designed to make some of the steps easier. Leger never reveals the name of participants to their client or anyone else nor will they use your information for any reason other than this survey. They will not contact you to participate in any other survey without your permission.

          • August 29, 2013 at 7:59 pm
          LynnLuc
          Participant

            PS    Leger is an independent market research company contracted by Merck to do a study for them . The objective of the study is to understand the impact of a new pen device instead of the current reconstitution  process on the interest, acceptance of physician recommendations to use interferon vs observation, and the likely duration of compliance with the new device.  The current process is complicated- diluent is added to the vial that is then drawn up and injected- the pen is designed to make some of the steps easier. Leger never reveals the name of participants to their client or anyone else nor will they use your information for any reason other than this survey. They will not contact you to participate in any other survey without your permission.

            • August 29, 2013 at 7:59 pm
            LynnLuc
            Participant

              PS    Leger is an independent market research company contracted by Merck to do a study for them . The objective of the study is to understand the impact of a new pen device instead of the current reconstitution  process on the interest, acceptance of physician recommendations to use interferon vs observation, and the likely duration of compliance with the new device.  The current process is complicated- diluent is added to the vial that is then drawn up and injected- the pen is designed to make some of the steps easier. Leger never reveals the name of participants to their client or anyone else nor will they use your information for any reason other than this survey. They will not contact you to participate in any other survey without your permission.

          Viewing 2 reply threads
          • You must be logged in to reply to this topic.
          About the MRF Patient Forum

          The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

          The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

          Popular Topics